title: Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts.
abstract: We sought evidence for non-MHC antibody-mediated rejection in renal allografts by a systematic study of rejected HLA-identical sibling renal allografts. Among 162 recipients of HLA-identical, ABO-compatible sibling donor kidneys transplanted at the Massachusetts General Hospital from 1964 to 2005, we identified 15 grafts that were lost from rejection and two additional grafts with reversible acute rejection, which provided 30 samples for study. All samples were stained for C4d by immunofluorescence in frozen tissue (n = 7) or by immunohistochemistry in paraffin embedded tissues (n = 10). We found that two of 17 grafts had positive C4d staining of peritubular capillaries. Histology revealed acute antibody-mediated rejection in one and acute cellular rejection type 1 in the other. Both grafts were matched at HLA-A, B, and C loci and had a nonreactive mixed lymphocyte response. Genotyping and serological analysis were not available. Compared with a published series, C4d+ irreversible rejection was more common in HLA nonidentical than HLA-identical grafts (75% vs 6.7%, respectively, P < .002). We conclude that antibody-mediated rejection, presumably due to non-MHC antigens other than ABO-blood groups does occur, but infrequently. This may account for some of the HLA antibody negative cases that develop antibody-mediated rejection.
authors.affiliation: Department of Pathology, Medical and Surgical Services of Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA. collins@helix.mgh.harvard.edu
authors.forename: A B
authors.initials: AB
authors.lastname: Collins
authors.forename: S L
authors.initials: SL
authors.lastname: Chicano
authors.forename: L D
authors.initials: LD
authors.lastname: Cornell
authors.forename: N
authors.initials: N
authors.lastname: Tolkoff-Rubin
authors.forename: N B
authors.initials: NB
authors.lastname: Goes
authors.forename: S L
authors.initials: SL
authors.lastname: Saidman
authors.forename: M L
authors.initials: ML
authors.lastname: Farrell
authors.forename: A B
authors.initials: AB
authors.lastname: Cosimi
authors.forename: R B
authors.initials: RB
authors.lastname: Colvin
mesh_terms: D000017:ABO Blood-Group System / Q000276:immunology*; D000328:Adult; D001787:Blood Group Incompatibility; D015935:Complement C4b / Q000276:immunology*; D006084:Graft Rejection / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007518:Isoantibodies / Q000097:blood*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D010446:Peptide Fragments / Q000276:immunology*; D012189:Retrospective Studies; D035781:Siblings; D014184:Transplantation, Homologous / Q000276:immunology
chemical_list: D000017:ABO Blood-Group System; D007518:Isoantibodies; D010446:Peptide Fragments; D015935:Complement C4b; C032261:complement C4d